Eric Joseph
Stock Analyst at JP Morgan
(1.25)
# 3,276
Out of 4,814 analysts
131
Total ratings
34.15%
Success rate
-15.65%
Average return
Main Sectors:
Stocks Rated by Eric Joseph
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PTCT PTC Therapeutics | Maintains: Overweight | $78 → $75 | $47.45 | +58.06% | 9 | Mar 31, 2025 | |
| BLUE bluebird bio | Upgrades: Neutral | n/a | $4.15 | - | 3 | Feb 24, 2025 | |
| PLRX Pliant Therapeutics | Downgrades: Neutral | n/a | $1.46 | - | 4 | Feb 10, 2025 | |
| NRIX Nurix Therapeutics | Maintains: Overweight | $31 → $30 | $9.32 | +221.89% | 7 | Jan 29, 2025 | |
| IGMS IGM Biosciences | Upgrades: Neutral | n/a | $1.24 | - | 8 | Jan 13, 2025 | |
| VIR Vir Biotechnology | Maintains: Neutral | $10 → $14 | $5.47 | +156.18% | 5 | Jan 9, 2025 | |
| RVMD Revolution Medicines | Maintains: Overweight | $63 → $71 | $36.75 | +93.20% | 6 | Dec 3, 2024 | |
| TGTX TG Therapeutics | Maintains: Overweight | $30 → $43 | $38.32 | +12.21% | 4 | Nov 25, 2024 | |
| SEPN Septerna | Initiates: Overweight | $38 | $5.88 | +546.26% | 1 | Nov 19, 2024 | |
| CAMP Camp4 Therapeutics | Initiates: Overweight | $23 | $1.91 | +1,104.19% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $17 | $5.92 | +187.16% | 2 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $23 → $21 | $2.70 | +679.22% | 5 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $8 → $9 | $6.00 | +50.00% | 7 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $45 → $48 | $16.25 | +195.38% | 3 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $11 → $10 | $5.13 | +94.93% | 4 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $54 | $6.33 | +753.08% | 2 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.69 | - | 4 | Jul 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $16 → $15 | $1.24 | +1,114.57% | 4 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $15 | $1.70 | +782.35% | 1 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $34 → $47 | $26.00 | +80.77% | 2 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $6 | $1.25 | +380.00% | 4 | Jan 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $10 | $5.50 | +81.82% | 2 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $31 → $11 | $4.55 | +141.76% | 2 | Oct 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $62 → $41 | $37.65 | +8.91% | 2 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $5 | $0.43 | +1,052.07% | 1 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $28 → $5 | $0.55 | +815.58% | 2 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $2.97 | - | 6 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $11 | $2.40 | +358.33% | 6 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $9.86 | - | 2 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $120 | $5.06 | +2,273.89% | 2 | Feb 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $750 → $300 | $4.69 | +6,296.59% | 2 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $6.83 | - | 2 | Oct 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $50 | $4.61 | +985.78% | 1 | Jul 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $24 → $9 | $1.43 | +529.37% | 2 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $2.06 | - | 4 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $42 | $1.44 | +2,816.67% | 1 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $11 → $13 | $0.73 | +1,688.17% | 2 | Jan 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $35 → $11 | $0.71 | +1,457.63% | 3 | Nov 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $1.43 | - | 3 | Mar 2, 2018 |
PTC Therapeutics
Mar 31, 2025
Maintains: Overweight
Price Target: $78 → $75
Current: $47.45
Upside: +58.06%
bluebird bio
Feb 24, 2025
Upgrades: Neutral
Price Target: n/a
Current: $4.15
Upside: -
Pliant Therapeutics
Feb 10, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.46
Upside: -
Nurix Therapeutics
Jan 29, 2025
Maintains: Overweight
Price Target: $31 → $30
Current: $9.32
Upside: +221.89%
IGM Biosciences
Jan 13, 2025
Upgrades: Neutral
Price Target: n/a
Current: $1.24
Upside: -
Vir Biotechnology
Jan 9, 2025
Maintains: Neutral
Price Target: $10 → $14
Current: $5.47
Upside: +156.18%
Revolution Medicines
Dec 3, 2024
Maintains: Overweight
Price Target: $63 → $71
Current: $36.75
Upside: +93.20%
TG Therapeutics
Nov 25, 2024
Maintains: Overweight
Price Target: $30 → $43
Current: $38.32
Upside: +12.21%
Septerna
Nov 19, 2024
Initiates: Overweight
Price Target: $38
Current: $5.88
Upside: +546.26%
Camp4 Therapeutics
Nov 5, 2024
Initiates: Overweight
Price Target: $23
Current: $1.91
Upside: +1,104.19%
Oct 17, 2024
Maintains: Overweight
Price Target: $13 → $17
Current: $5.92
Upside: +187.16%
Sep 10, 2024
Maintains: Overweight
Price Target: $23 → $21
Current: $2.70
Upside: +679.22%
Aug 12, 2024
Maintains: Underweight
Price Target: $8 → $9
Current: $6.00
Upside: +50.00%
Aug 7, 2024
Maintains: Overweight
Price Target: $45 → $48
Current: $16.25
Upside: +195.38%
Aug 6, 2024
Maintains: Underweight
Price Target: $11 → $10
Current: $5.13
Upside: +94.93%
Aug 6, 2024
Maintains: Overweight
Price Target: $50 → $54
Current: $6.33
Upside: +753.08%
Jul 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.69
Upside: -
May 13, 2024
Maintains: Overweight
Price Target: $16 → $15
Current: $1.24
Upside: +1,114.57%
May 3, 2024
Maintains: Neutral
Price Target: $14 → $15
Current: $1.70
Upside: +782.35%
Feb 23, 2024
Maintains: Overweight
Price Target: $34 → $47
Current: $26.00
Upside: +80.77%
Jan 29, 2024
Upgrades: Neutral
Price Target: $6
Current: $1.25
Upside: +380.00%
Nov 13, 2023
Maintains: Neutral
Price Target: $11 → $10
Current: $5.50
Upside: +81.82%
Oct 19, 2023
Maintains: Overweight
Price Target: $31 → $11
Current: $4.55
Upside: +141.76%
Oct 11, 2023
Maintains: Overweight
Price Target: $62 → $41
Current: $37.65
Upside: +8.91%
Aug 28, 2023
Downgrades: Neutral
Price Target: $15 → $5
Current: $0.43
Upside: +1,052.07%
Aug 28, 2023
Downgrades: Neutral
Price Target: $28 → $5
Current: $0.55
Upside: +815.58%
Aug 10, 2023
Downgrades: Underweight
Price Target: n/a
Current: $2.97
Upside: -
Aug 9, 2023
Maintains: Neutral
Price Target: $10 → $11
Current: $2.40
Upside: +358.33%
Nov 29, 2022
Downgrades: Underweight
Price Target: n/a
Current: $9.86
Upside: -
Feb 9, 2022
Upgrades: Neutral
Price Target: $120
Current: $5.06
Upside: +2,273.89%
Jan 7, 2022
Downgrades: Neutral
Price Target: $750 → $300
Current: $4.69
Upside: +6,296.59%
Oct 8, 2021
Downgrades: Underweight
Price Target: n/a
Current: $6.83
Upside: -
Jul 12, 2021
Initiates: Neutral
Price Target: $50
Current: $4.61
Upside: +985.78%
Jan 29, 2021
Downgrades: Neutral
Price Target: $24 → $9
Current: $1.43
Upside: +529.37%
Jan 29, 2021
Downgrades: Underweight
Price Target: n/a
Current: $2.06
Upside: -
Feb 24, 2020
Initiates: Overweight
Price Target: $42
Current: $1.44
Upside: +2,816.67%
Jan 24, 2019
Upgrades: Neutral
Price Target: $11 → $13
Current: $0.73
Upside: +1,688.17%
Nov 14, 2018
Maintains: Neutral
Price Target: $35 → $11
Current: $0.71
Upside: +1,457.63%
Mar 2, 2018
Downgrades: Underweight
Price Target: n/a
Current: $1.43
Upside: -